Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of rhPTH(1-84) in adults with hypoparathyroidism
2008-005063-34Phase 3Completed
- Sponsor
- NPS Pharmaceuticals, Inc.
- Start
- Nov 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in hypoparathyroidism comparing rhPTH(1-84) with Placebo (2 arms). Started Nov 2008; status: completed.
02
Drugs
parathyroid hormone 1-84
03
Conditions
hypoparathyroidism
Beyond the preview
Go deeper on 2008-005063-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005063-34.